• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Verisyse/Artisan有晶体眼人工晶状体植入术后具有视觉意义的白内障形成和角膜失代偿的发生率及发生情况。

Incidence rate and occurrence of visually significant cataract formation and corneal decompensation after implantation of Verisyse/Artisan phakic intraocular lens.

作者信息

Moshirfar Majid, Imbornoni Lauren M, Ostler Erik M, Muthappan Valliammai

机构信息

Moran Eye Center, Department of Ophthalmology and Visual Sciences, University of Utah, Salt Lake City, UT, USA.

University of Arizona College of Medicine, Tucson, AZ, USA.

出版信息

Clin Ophthalmol. 2014 Apr 8;8:711-6. doi: 10.2147/OPTH.S59878. eCollection 2014.

DOI:10.2147/OPTH.S59878
PMID:24748765
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3986296/
Abstract

PURPOSE

To evaluate the incidence rate and indications for explantation of Verisyse phakic intraocular lenses (pIOLs) over a 13.6 year period.

SUBJECTS AND METHODS

Case series describing six cases of explantation of Verisyse pIOLs, out of 213 eyes with Verisyse pIOLs, implanted over a 13.6 year period by one surgeon at one institution, with mean follow-up of 5.6 years per eye.

RESULTS

Four pIOLs were removed to facilitate extraction of a visually significant cataract, one was removed due to both cataract formation and development of corneal decompensation, and another was removed due to development of localized peripheral corneal decompensation. The incidence rate of pIOL removal was five per 1,000 patient-years with pIOL. Mean time from insertion of pIOL to cataract removal was 9.3 years (range 4.0-12.6 years). Mean time from insertion of pIOL to development of corneal decompensation was 10 years (range 6.9-13 years). There was no increase in the rate of cataract extraction in the pIOL population compared to the general population.

CONCLUSION

Cataracts may develop in patients with pIOLs, necessitating removal of the pIOL. Corneal decompensation is a serious complication that appears to be directly related to pIOLs. Corneal decompensation can occur up to 13 years following implantation of pIOLs, and long-term follow-up is important to monitor for this complication.

摘要

目的

评估Verisyse有晶状体眼人工晶状体(pIOL)在13.6年期间的取出发生率及取出指征。

对象与方法

病例系列描述了在13.6年期间由一名外科医生在一家机构植入Verisyse pIOL的213眼中,有6例Verisyse pIOL取出的情况,每只眼平均随访5.6年。

结果

4枚pIOL因便于取出具有明显视力影响的白内障而被取出,1枚因白内障形成和角膜失代偿发展而被取出,另一枚因局限性周边角膜失代偿发展而被取出。pIOL取出的发生率为每1000患者 - 年有5例。从pIOL植入到白内障取出的平均时间为9.3年(范围4.0 - 12.6年)。从pIOL植入到角膜失代偿发展的平均时间为10年(范围6.9 - 13年)。与普通人群相比,pIOL人群中的白内障摘除率没有增加。

结论

pIOL患者可能会发生白内障,需要取出pIOL。角膜失代偿是一种严重并发症,似乎与pIOL直接相关。角膜失代偿可在pIOL植入后长达13年发生,长期随访对于监测这种并发症很重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a574/3986296/67396741e847/opth-8-711Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a574/3986296/67396741e847/opth-8-711Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a574/3986296/67396741e847/opth-8-711Fig1.jpg

相似文献

1
Incidence rate and occurrence of visually significant cataract formation and corneal decompensation after implantation of Verisyse/Artisan phakic intraocular lens.Verisyse/Artisan有晶体眼人工晶状体植入术后具有视觉意义的白内障形成和角膜失代偿的发生率及发生情况。
Clin Ophthalmol. 2014 Apr 8;8:711-6. doi: 10.2147/OPTH.S59878. eCollection 2014.
2
Phakic intraocular lenses for the treatment of refractive errors: an evidence-based analysis.用于治疗屈光不正的有晶状体眼人工晶状体:一项基于证据的分析。
Ont Health Technol Assess Ser. 2009;9(14):1-120. Epub 2009 Oct 1.
3
Visual Prognosis Following Cataract Surgery in Highly Myopic Patients with Prior History of Verisyse Phakic Intraocular Lens Implantation.有Verisyse有晶体眼人工晶状体植入史的高度近视患者白内障手术后的视力预后
J Clin Med. 2024 Aug 13;13(16):4760. doi: 10.3390/jcm13164760.
4
Cataract surgery following phakic intraocular lens implantation.有晶状体眼人工晶状体植入术后白内障手术。
Curr Opin Ophthalmol. 2010 Jan;21(1):39-44. doi: 10.1097/ICU.0b013e328333ea2f.
5
Phakic intraocular lens explantation: causes in 240 cases.有晶状体眼人工晶状体取出术:240例病因分析
J Refract Surg. 2015 Jan;31(1):30-5. doi: 10.3928/1081597X-20141202-01. Epub 2014 Dec 9.
6
Management of corneal endothelial decompensation caused by iris-fixated phakic intraocular lenses with descemet stripping automated endothelial keratoplasty.虹膜固定型有晶状体眼人工晶状体引起的角膜内皮失代偿的治疗:去表皮自动角膜内皮移植术。
Cornea. 2011 Sep;30(9):1045-7. doi: 10.1097/ICO.0b013e3182035dd0.
7
Long-Term Endothelial Cell Loss in Patients with Artisan Myopia and Artisan Toric Phakic Intraocular Lenses: 5- and 10-Year Results.工匠性近视患者和工匠性散光型有晶状体眼人工晶状体植入术后的长期内皮细胞丢失:5 年和 10 年结果。
Ophthalmology. 2018 Apr;125(4):486-494. doi: 10.1016/j.ophtha.2017.08.011. Epub 2017 Sep 19.
8
Five-year follow-up of 399 phakic Artisan-Verisyse implantation for myopia, hyperopia, and/or astigmatism.对399例接受有晶体眼Artisan-Verisyse人工晶状体植入术治疗近视、远视和/或散光患者的五年随访。
Ophthalmology. 2008 Jun;115(6):1002-12. doi: 10.1016/j.ophtha.2007.08.022. Epub 2007 Nov 5.
9
[Clinical analysis of long term safety after implantation of iris-fixed phakic intraocular lens Verisyse].虹膜固定型有晶状体眼人工晶状体Verisyse植入术后长期安全性的临床分析
Zhonghua Yan Ke Za Zhi. 2012 Aug;48(8):707-12.
10
Iris-fixated phakic intraocular lens explantation.虹膜固定型有晶状体眼人工晶状体取出术。
Eur J Ophthalmol. 2021 May;31(3):988-993. doi: 10.1177/1120672120934985. Epub 2020 Jun 14.

引用本文的文献

1
Iris-Claw Anterior Chamber Phakic Intraocular Lens Explantation: A Case Series.虹膜爪型前房有晶状体眼人工晶状体取出术:病例系列
J Curr Ophthalmol. 2024 Aug 10;35(4):332-336. doi: 10.4103/joco.joco_137_23. eCollection 2023 Oct-Dec.
2
Visual Prognosis Following Cataract Surgery in Highly Myopic Patients with Prior History of Verisyse Phakic Intraocular Lens Implantation.有Verisyse有晶体眼人工晶状体植入史的高度近视患者白内障手术后的视力预后
J Clin Med. 2024 Aug 13;13(16):4760. doi: 10.3390/jcm13164760.
3
Descemet's Membrane Endothelial Keratoplasty for Corneal Endothelial Failure Secondary to Three Types of Phakic Intraocular Lens - Retrospective Study.

本文引用的文献

1
Posterior chamber phakic intraocular lens to correct myopia: long-term follow-up.后房型有晶状体眼人工晶状体矫正近视:长期随访。
J Cataract Refract Surg. 2013 Jul;39(7):1023-8. doi: 10.1016/j.jcrs.2013.01.041. Epub 2013 May 8.
2
Visual outcome and complications after posterior iris-claw aphakic intraocular lens implantation.后房型虹膜夹型人工晶状体植入术后的视力结果和并发症。
J Cataract Refract Surg. 2012 Dec;38(12):2139-43. doi: 10.1016/j.jcrs.2012.07.035. Epub 2012 Oct 2.
3
Iris-fixated phakic intraocular lens implantation for correction of high myopia in microspherophakia.
用于三种有晶状体眼人工晶状体继发角膜内皮功能衰竭的Descemet膜内皮角膜移植术——回顾性研究
Clin Ophthalmol. 2023 Mar 19;17:931-940. doi: 10.2147/OPTH.S401387. eCollection 2023.
4
Comparison of preoperative simulated and postoperative real safety distances using anterior segment OCT in patients with phakic IOL according to iris configuration.根据虹膜形态,使用眼前节光学相干断层扫描(OCT)对有晶状体眼人工晶状体植入术患者术前模拟和术后实际安全距离进行比较。
Int J Ophthalmol. 2022 May 18;15(5):741-746. doi: 10.18240/ijo.2022.05.08. eCollection 2022.
5
Two-year results after combined phacoemulsification and iris-fixated phakic intraocular lens removal.超声乳化白内障吸除联合虹膜固定型有晶状体眼人工晶状体取出术后两年的结果。
Graefes Arch Clin Exp Ophthalmol. 2022 Apr;260(4):1367-1375. doi: 10.1007/s00417-021-05442-3. Epub 2021 Oct 16.
6
Phakic intraocular lenses: An overview.有晶状体眼人工晶状体:概述。
Indian J Ophthalmol. 2020 Dec;68(12):2779-2796. doi: 10.4103/ijo.IJO_2995_20.
7
Long-term endothelial cell loss with the iris-claw intraocular phakic lenses (Artisan®).虹膜扣型有晶状体眼人工晶状体(Artisan®)导致的长期内皮细胞丢失。
Graefes Arch Clin Exp Ophthalmol. 2019 Dec;257(12):2775-2787. doi: 10.1007/s00417-019-04506-9. Epub 2019 Oct 28.
8
Efficacy of Different Procedures of Intra-Corneal Ring Segment Implantation in Keratoconus: a Systematic Review and Meta-Analysis.圆锥角膜中不同角膜内环植入术的疗效:一项系统评价和荟萃分析
Transl Vis Sci Technol. 2019 Jun 11;8(3):38. doi: 10.1167/tvst.8.3.38. eCollection 2019 May.
9
Verisyse versus Veriflex Phakic Intraocular Lenses: Refractive Outcomes and Endothelial Cell Density 5 Years after Surgery.Verisyse与Veriflex有晶状体眼人工晶状体:术后5年的屈光结果和内皮细胞密度
J Ophthalmol. 2018 Sep 30;2018:4210460. doi: 10.1155/2018/4210460. eCollection 2018.
10
MyoRing treatment of myopia.MyoRing治疗近视。
J Optom. 2017 Jul-Sep;10(3):194-198. doi: 10.1016/j.optom.2016.06.003. Epub 2016 Jul 25.
虹膜固定型有晶状体眼人工晶状体植入术矫正小眼球高度近视。
J Cataract Refract Surg. 2010 Apr;36(4):682-5. doi: 10.1016/j.jcrs.2009.08.043.
4
Cataract surgery following phakic intraocular lens implantation.有晶状体眼人工晶状体植入术后白内障手术。
Curr Opin Ophthalmol. 2010 Jan;21(1):39-44. doi: 10.1097/ICU.0b013e328333ea2f.
5
Case of late-onset corneal decompensation after iris-fixated phakic intraocular lens implantation.虹膜固定型有晶状体眼人工晶状体植入术后迟发性角膜失代偿病例。
J Cataract Refract Surg. 2009 Apr;35(4):774-7. doi: 10.1016/j.jcrs.2008.09.032.
6
Corneal endothelial decompensation after iris-claw phakic intraocular lens implantation.虹膜爪型有晶状体眼人工晶状体植入术后的角膜内皮失代偿
J Cataract Refract Surg. 2008 Mar;34(3):517-9. doi: 10.1016/j.jcrs.2007.10.030.
7
[Brown-McLean syndrome and refractive phakic anterior chamber intraocular lenses].[布朗-麦克林综合征与可折射有晶状体眼人工晶状体]
Arch Soc Esp Oftalmol. 2007 Dec;82(12):737-8; author reply 738-9. doi: 10.4321/s0365-66912007001200004.
8
Three-year results of Artisan/Verisyse phakic intraocular lens implantation. Results of the United States Food And Drug Administration clinical trial.阿蒂桑/维瑞西(Artisan/Verisyse)有晶状体眼人工晶状体植入术的三年结果。美国食品药品监督管理局临床试验结果
Ophthalmology. 2008 Mar;115(3):464-472.e1. doi: 10.1016/j.ophtha.2007.08.039. Epub 2007 Nov 26.
9
Five-year follow-up of 399 phakic Artisan-Verisyse implantation for myopia, hyperopia, and/or astigmatism.对399例接受有晶体眼Artisan-Verisyse人工晶状体植入术治疗近视、远视和/或散光患者的五年随访。
Ophthalmology. 2008 Jun;115(6):1002-12. doi: 10.1016/j.ophtha.2007.08.022. Epub 2007 Nov 5.
10
Ten-year incidence of age-related cataract and cataract surgery in an older Australian population. The Blue Mountains Eye Study.澳大利亚老年人群中年龄相关性白内障及白内障手术的十年发病率。蓝山眼研究。
Ophthalmology. 2008 May;115(5):808-814.e1. doi: 10.1016/j.ophtha.2007.07.008. Epub 2007 Sep 27.